Predicting the binding mode of flexible polypeptides to proteins is an important task that falls outside the domain of applicability of most small molecule and protein−protein docking tools. Here, we test the small molecule flexible ligand docking program Glide on a set of 19 non-α-helical peptides and systematically improve pose prediction accuracy by enhancing Glide sampling for flexible polypeptides. In addition, scoring of the poses was improved by post-processing with physics-based implicit solvent MM- GBSA calculations. Using the best RMSD among the top 10 scoring poses as a metric, the success rate (RMSD ≤ 2.0 Å for the interface backbone atoms) increased from 21% with default Glide SP settings to 58% with the enhanced peptide sampling and scoring protocol in the case of redocking to the native protein structure. This approaches the accuracy of the recently developed Rosetta FlexPepDock method (63% success for these 19 peptides) while being over 100 times faster. Cross-docking was performed for a subset of cases where an unbound receptor structure was available, and in that case, 40% of peptides were docked successfully. We analyze the results and find that the optimized polypeptide protocol is most accurate for extended peptides of limited size and number of formal charges, defining a domain of applicability for this approach.
Mendeley helps you to discover research relevant for your work.
CITATION STYLE
John H. Krystal, MD; Laurence P. Karper, MD; John P. Seibyl, MD; Glenna K. Freeman; Richard Delaney, PhD; J. Douglas Bremner, MD; George R. Heninger, MD; Malcolm B. Bowers, Jr, MD; Dennis S. Charney, MDJohn H. Krystal, MD; Laurence P. Karper, MD; John P., M. (1994). Subanesthetic Effects of the Noncompetitive NMDA Antagonist, Ketamine, in Humans. Archives of General Psychiatry, 51(March 3), 199–214.